FAILURE OF SGLT-2 INHIBITOR IN THE CONTEXT OF NEW ILEAL CONDUIT FORMATION

WCN23-0953
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
 
 
 
 
FAILURE OF SGLT-2 INHIBITOR IN THE CONTEXT OF NEW ILEAL CONDUIT FORMATION
Almog, J.(1)*;Jain, S.(2);Pybass, P.(3);Gupta, A.(4);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Te Whatu Ora - Health New Zealand Midcentral District- Palmerston North Hospital, Renal, Palmerston North, New Zealand;(2)Te Whatu Ora - Health New Zealand Midcentral District, Diabetes Clinical Nurse Specialist Services, Palmerston North, New Zealand;(3)Te Whatu Ora - Health New Zealand Midcentral District, Internal Medicine, Palmerston North, New Zealand;(4)Te Whatu Ora - Health New Zealand Midcentral District, Renal, Palmerston North, New Zealand;
https://storage.unitedwebnetwork.com/files/1041/5481565eea5816c663d6bea9060e665e.pdf
 
if any